In a study of Blue Cross and Blue Shield enrollees reported last week in the New England Journal of Medicine, initial opioid prescriptions declined 54 percent between July 2012 and December 2017, while the number of providers who initiated opioid therapy in any patient who had not used opioids declined by 29 percent. The incidence of long-duration and high-dose initial opioid prescriptions also declined over the study period. “Notably, these downward trends began long before the release of the CDC [Centers for Disease Control and Prevention] guidelines in March 2016 (or even the draft guidelines in December 2015), indicating that the CDC guidelines were not the sole precipitating force behind the declines,” the authors said. In March 2016, CDC finalized guidance for primary care physicians prescribing opioids to adults for chronic pain in outpatient settings, which emphasized limiting the use, duration and dose of opioids for first-time users. 

Related News Articles

Headline
Oct. 28 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired tablets, capsules, patches and…
Headline
Federal agencies last month stopped over 500 unapproved pharmaceutical products and medical devices, including opioid and other controlled substances, from…
Headline
As the House Energy and Commerce Committee works to reauthorize key programs within the Substance Use-Disorder Prevention that Promotes Opioid Recovery and…
Headline
While counseling and other services are an important part of a comprehensive treatment plan for opioid use disorder, the provision of medication should not be…
Headline
AHA today launched an updated Opioid Stewardship Hub, featuring the latest tools and resources to help hospitals and health systems address the opioid epidemic…
Headline
The Food and Drug Administration last week required certain labeling updates for opioid pain medicines in an effort to reduce unnecessary prescribing and…